Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells
Nature Medicine1996Vol. 2(5), pp. 561–566
Citations Over TimeTop 1% of 1996 papers
Brian Druker, Shu Tamura, Elisabeth Buchdunger, Sayuri Ohno, Gerald M. Segal, Shane Fanning, J. Zimmermann, Nicholas Lydon
Related Papers
- Detection of BCR-ABL proteins in blood cells of benign phase chronic myelogenous leukemia patients.(1991)
- → The ABL oncogene in human leukemias(1988)8 cited
- Breakpoint localization within the M-bcr and clinical course do not correlate in patients with chronic myelogenous leukemia undergoing alfa interferon therapy.(1991)
- → Molecular Biological Investigation in Chronic Myelogenous Leukemia Patients Undergoing Interferon Therapy(1988)1 cited
- Expression of bcr/abl fusion gene in chronic myelogenous leukemia(2003)